The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Innovative Molecules competitive analysis

Loading summary...

Latest oppositions filed by Innovative Molecules

Explore patent oppositions filed by Innovative Molecules against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3544976
N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses ThereofAICURISNov 17, 2021

Latest patents of Innovative Molecules opposed by its competitors

Explore Innovative Molecules's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3440063
Aug 5, 2020Aminothiazole Derivatives Useful As Antiviral Agents1

Latest PTAB cases involving Innovative Molecules

Discover the latest PTAB cases involving Innovative Molecules, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Innovative Molecules with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INNOVATIVE MOLECULES11 - -
AICURIS - 1 - -
AICURIS ANTI INFECTIVE CURES11 - -